Objective: This study examined the effects of total and partial sleep deprivation on subjective symptoms and objective neurocognitive performance, as measured by the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) in a sample of healthy adults. Method: One-hundred and two, right-handed, healthy participants (between ages 18 and 30 years old) completed three consecutive nights in the sleep laboratory with concurrent continuous polysomnography monitoring. Night 1 served as a baseline night. Prior to Night 2, they were randomly assigned to one of three sleep conditions: undisrupted normal sleep (N = 34), sleep restriction (50% of habitual sleep, N = 37), or total sleep deprivation (N = 31). Participants slept undisturbed on Night 3. ImPACT was administered on three separate occasions. Results: Sleep loss was associated with increased severity of subjectively reported affective, cognitive, physical, and sleep symptoms. Although objective neurocognitive task scores derived from the ImPACT battery did not corroborate subjective complaints, sleep loss was associated with significant differences on tasks of visual memory, reaction time, and visual motor speed over time. Conclusions: While self-report measures suggested marked impairments following sleep loss, deficits in neurocognitive performance were observed only on three domains measured with ImPACT. ImPACT may capture subtle changes in neurocognitive performance following sleep loss; however, independent and larger validation studies are needed to determine its sensitivity to acute sleep loss and recovery sleep. Neurocognitive screening batteries may be useful for detecting the effects of more severe or chronic sleep loss under high-stress conditions that mimic high-risk occupations.
Introduction
The relationship between sleep disturbances and their negative effects on neurocognitive performance is well established (Dinges et al., 1997; Harrison & Horne, 2000; Kleitman, 1963; Kribbs & Dinges, 1994; Mihalik et al., 2013; Patrick & Gilbert, 1896; Pilcher & Huffcutt, 1996; Wilkinson, 1968) . Sleep deprivation (SD) affects cognitive functioning across a number of domains, including, but not limited to: attention; information processing speed; psychomotor reaction time; working memory; learning and immediate memory recall; abstract reasoning; inhibition of previously learned responses and impulses; and decreased awareness to present situations and circumstances (see Goel, Rao, Durmer, & Dinges, 2009 for review). However, not all neurocognitive functions are equally sensitive to the effects of sleep loss (Goel et al., 2009) .
For instance, processing speed, simple decision making, working memory, and aspects of attention have been found to be susceptible to decrements in performance following both acute and chronic sleep loss (Dinges, 1992; Goel et al., 2009) , whereas performance on tasks requiring higher level, complex skills (i.e., critical reasoning, complex decision making, and
Materials and Methods
The present study was an ancillary study to a larger sleep study focused on the effects of sleep loss of positive and negative affect in healthy individuals (Log#11293006). The study was approved by the Institutional Review Board at the University of Pittsburgh and U.S. Department of Defense Human Research Protection Office.
Eligible participants were women and men between the ages of 18 and 30 years. All were free of medications known to affect sleep (e.g., hypnotics, benzodiazepines, antidepressants, anxiolytics, stimulants, antipsychotics, decongestants and sedating antihistamines, beta blockers, and corticosteroids). After providing written, informed consent, participants completed a series of screening procedures to confirm eligibility, which included a medical review, self-report questionnaires, clinicianadministered interviews, and an in-home sleep assessment.
One-hundred and two, right-handed, healthy participants (n = 45 men, n = 57 women) between the ages of 18 and 30 (mean age = 23.76 + 3.36 years old) completed the intake clinical assessments, self-report measures, and an ambulatory sleep screening study to ascertain the absence of psychiatric, medical, and sleep disorders.
All completed a medical evaluation, during which prior history of TBI and presence of current concussive symptoms was evaluated. To guide the medical review, participants, regardless of military veteran status, completed the 3-item Defense and Veterans Brain Injury Center Brief Traumatic Brain Injury Screen (Schwab et al., 2006) to evaluate for history of brain injuries, resulting alterations or loss of consciousness, and current concussive symptoms (e.g., headaches, dizziness, tinnitus, and vestibular problems). If a history of head injury was reported, the nature and duration of symptoms following the injury was then evaluated. None of the participants enrolled in the study endorsed current symptoms related to TBI. Of the 34 participants who endorsed a history of concussion (normal sleep [NS] , N = 15 [44.12% of NS condition]; sleep restriction [SR] , N = 11 [29.73 of SR condition]; and SD, N = 8 [25.81% of SD condition]), 14 also endorsed experiencing post-concussive symptoms subsequent to the concussive event (NS, N = 6 [17.65% of NS condition]; SR, N = 5 [13.51% of SR condition]; and SD, N = 3 [9.68% of SD condition]). However, none of the participants endorsed experiencing current post-concussive symptoms at study entry.
All participants completed a battery of self-report screening measures to ascertain the absence of sleep disturbances. These included the Insomnia Severity Index (ISI; Bastien, Vallieres, & Morin, 2001) ; the Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) ; the Pittsburgh Sleep Quality Index-Addendum for PTSD Study (PSQIA; Germain, Hall, Krakow, Shear, & Buysse, 2005) ; and the Epworth Sleepiness Scale (ESS; Johns, 1991) . Only participants who endorsed scores below clinical cutoffs for each of these measures were eligible to participate.
Certified masters or doctoral level assessors administered the locally developed Structured Clinical Interview for DSM-IV Sleep Disorders (SCID-SLD; Buysse et al., 2008 Buysse et al., , 2011 Germain et al., 2006 Germain et al., , 2012 to rule out the presence of current and past core symptoms of insomnia, sleep-disordered breathing, restless legs syndrome and other sleep-related movement disorders, and parasomnias, as defined by the International Classification of Sleep Disorders-3rd Edition (American Academy of Sleep Medicine, 2014) and DSM-IV-TR (American Psychiatric Association, 2000) . To rule out sleep apnea, participants completed an in-home study using a portable two-channel apnea screening device (ApneaLink Plus TM ; ResMed Corporation, Poway, CA). Eligible participants were free of significant sleep-disordered breathing, and had an apnea-hypopnea index (AHI) <5 on their screening night.
The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID; First, Spitzer, Gibbon, & Williams, 1996) was administered in order to verify the absence of mood, anxiety, or alcohol/substance use disorders within the past 6 months. The absence of PTSD symptoms was verified using the Clinician-Administered PTSD Scale (CAPS, Blake et al., 1995) the gold standard for PTSD assessment using the 1F-2I scoring rule.
Eligible participants received a sleep diary to complete at home over two 7-10 day periods. These diaries gathered more information about their sleep schedule and habits that may influence sleep. They were also required to wear a wrist actigraphy device (Philips-Respironics Actiwatch2, Murrysville, PA) to monitor activity level (derived from wrist movements) to verify that they maintained regular sleep schedules and sufficient sleep. Eligible participants showed actigraphy-based mean sleep latency <30 min, wake time after sleep onset <30 min, and mean sleep efficiency >85%, which is considered optimal (Spielman, Saskin, & Thorpy, 1987) .
Experimental Design and Procedures
Participants enrolled in the experimental phase of the study underwent three consecutive nights of polysomnography (PSG) in the Neuroscience Clinical and Translational Research Center (N-CTRC; RR024153). On Night 1, all participants slept undisturbed according to their habitual usual bedtime and rise time. Participants were then free to leave the laboratory for the day, and were reminded to refrain from caffeine, alcohol, stimulants, or medications. Participants returned to the laboratory at 17:00 for the second night, where they remained until the morning after Night 3. Prior to their habitual bedtime on Night 2, participants were randomly assigned to one of three sleep conditions: undisrupted NS, SR (50% of habitual sleep duration), or total SD.
Participants randomized to NS were allowed to sleep undisturbed for the entire night during Night 2, and awakened at their usual rise time. They were then asked to stay awake the following day (approximately 16 h total awake time). Participants randomized to the SR condition were awakened after sleeping for 50% of their habitual sleep duration. They were asked to stay awake for the rest of the night in the sleep laboratory, and asked to remain awake the following day (mean time awake = 19.97 h, standard deviation [s.d.] = 0.26) to complete procedures of the parent study prior to their usual bedtime. Participants randomized to the sleep deprivation condition were asked to stay awake for the entire night in the sleep laboratory and the following day (mean total time awake = 39.98 h, s.d. = 0.42). Participants we continuously monitored with PSG to monitor sleep and ensure that they remained awake.
On Night 3, participants were allowed to sleep undisturbed at their usual bedtime until their usual waking time. This served as the recovery night. Upon waking following Night 3, participants remained in the laboratory until approximately 12:00 p.m. to complete additional procedures.
All participants underwent three separate administrations of ImPACT version 2.0, that includes a 21-item post-concussive symptom scale in addition to the neurocognitive battery . Prior to their usual bedtime on Night 2, participants completed their first administration of ImPACT (T1). The second completion of ImPACT (T2) occurred prior to their usual bedtime on Night 3. The final administration of ImPACT (T3) was completed prior to departing the laboratory in the morning following Night 3.
Statistical Analyses
A Chi-squared test was first conducted to evaluate whether the rates of self-reported history of head injuries and subsequent symptoms of those head injuries differed in participants randomly assigned to NS, SR, and SD. Additional analyses were conducted to determine whether sleep disturbances (as measured by the PSQI, PSQIA, ESS, and ISI) differed in participants randomly assigned to NS, SR, and SD. Distributions were verified for normality, and Kruskal-Wallis H-tests were conducted for variables with non-normal distributions that were unable to be transformed as needed.
Friedman's tests and Kruskal-Wallis H-tests were conducted in order to determine the effects of sleep manipulation on: (a) subjectively reported affective (i.e., nervousness, feeling more emotional, irritability, and sadness), cognitive (i.e., difficulty concentrating, difficulty remembering, and feeling "mentally foggy"), physical (i.e., fatigue or feeling "slowed down," headache, dizziness, sensitivity to light and/or noise, vision problems, balance problems, numbness, and nausea or vomiting), and sleep symptoms (i.e., sleeping more than usual, sleeping less than usual, trouble falling asleep, and drowsiness); and (b) objective cognitive performance as measured by ImPACT. The analyses were conducted due to violations of the assumption of normality in the distribution of the collected ImPACT data utilizing Shapiro-Wilk's test for normality. To examine within-group differences (NS, SR, and SD) of ImPACT self-reported subjective symptoms and objective neurocognitive performance across time (T1, T2, and T3), Friedman's tests were performed. To assess between-group differences on these same subjective symptoms and neurocognitive performance at each administration time point, Kruskal-Wallis H-tests were conducted. Analyses were conducted using the Statistical Package for the Social Sciences, version 21 (SPSS, version 21) on the 102 participants found to have completed all three ImPACT administrations necessary for the analyses (Friedman's tests and Kruskal-Wallis H-tests results are provided in Tables 2, 4 , 6, and 8 for completeness). All distributions were checked for similarity and were assessed by visual examination of box plots. All post hoc analyses for statistically significant Friedman's tests utilized Wilcoxon signed-rank tests with a Bonferroni correction for multiple comparisons. Post hoc Mann-Whitney U-tests with a Bonferroni correction for multiple comparisons were conducted for significant Kruskal-Wallis H-tests in order to control for Type I error. As a result of the Bonferroni correction for multiple comparisons, statistical significance was accepted at the p < .017 level. These results are provided in Tables 3, 5 , 7, and 9 for completeness. Adjusted p-values with Bonferroni corrections are presented.
Results

Sample Characteristics
One-hundred and two, right-handed, healthy participants (n = 45 men, n = 57 women) between the ages of 18 and 30 (mean age = 23.76 ± 3.36 years old) completed the parent study procedures and completed the ImPACT at all three time points. Demographic, clinical measures, AHI, and distributions of history of head injury and concussive symptoms for participants randomized to the NS, SR, and SD condition are provided in Table 1 . The median ISI, PSQI, PSQI-Q, ESS scores and mean AHI for each group are also included in Table 1 . There were no statistically significant differences between groups regarding demographics, clinical measure outcomes, or AHI. The proportion of participants with history of head injury and the proportion of participants with history of post-concussive symptoms (not current) did not differ between the three sleep conditions, χ 2 (2, n = 102) = 2.79, p = .25 and χ 2 (2, n = 102) = 3.98, p = .41, respectively. The median or mean ranks of self-reported sleep difficulties (PSQI, PSQIA, ESS, and ISI) did not differ between the three sleep conditions. None of the participants endorsed symptoms of sleep difficulties on any of the screening measures that were elevated to clinical threshold.
Among the 102 participants who completed the ImPACT computerized battery, 34 were randomized to the NS condition (23.78 ± 3.85 years old), 37 were randomized to the SR condition (24.10 ± 3.32 years old), and 31 were randomly assigned to the total SD condition (23.34 ± 2.86 years old).
Subjective Symptoms Reported on ImPACT
Within-group differences. The median scores of subjective symptoms measured by ImPACT and the related-samples Friedman's two-way analysis of variance by ranks of subjective symptoms over time for the NS, SR, and SD conditions are provided in Table 2 . Comparisons between T1 and T2, and T2 and T3 are provided in the following analyses. Differences between T1 and T3 are not reported as they represent the combined effect of changes observed between T1 and T2, and T2 and T3.
When examining total symptom scores, there were significant differences across time for all three sleep conditions. Median total symptom scores during the NS condition were significantly different at the different time points (χ 2 (2) = 17.12, p < .001). Wilcoxon signed-rank test post hoc analyses (see Table 3 ) revealed a significant decrease in total symptoms over time (from T1 to T3 [Z = −2.97, p = .003, effect size = .35]). Median total symptoms during SR were significantly different across time points (χ 2 (2) = 39.34, p < .001). Post hoc analyses revealed significantly increased symptoms from T1 to T2 (Z = −5.26, p < .001, effect size = .64), and a significant decrease in total symptoms between T2 and T3 (Z = −4.03, p < .001, effect size = .51). Median total symptoms during total SD were significantly different across time points (χ 2 (2) = 43.19, p < .001). Post hoc analyses revealed a significant increase in symptoms between T1 and T2 (Z = −4.76, p < .001, effect size = .58), and a significant reduction in symptoms from T2 to T3 (Z = −3.88, p < .001, effect size = .49).
Between-group differences. The median scores of ImPACT subjective symptoms, and Kruskal-Wallis H-tests median or mean rank between-group (NS, SR, and SD) differences at T1, T2, and T3, are provided in Table 4 . When examining total symptoms scores, there were significant between-group differences at T2 (χ 2 (2) = 50.03, p < .001) and T3 (χ 2 (2) = 32.48, p < .001). Follow-up Mann-Whitney U-tests (see Table 5 ) were performed with a Bonferroni correction for multiple comparisons. This analysis revealed a statistically significant difference in total symptoms at T2 between the NS (1.70) and the SR (14.80) conditions (Z = −6.16, p < .001, effect size = .73) , the NS (1.70) and the SD (22.40) conditions (Z = −5.81, p < .001, effect size = .72), and between the SR (14.80) and SD (22.40) conditions (Z = −2.23, p = .026, effect size = .27; see Table 5 ). Post hoc analyses 17.65 (6) 13.51 (5) 9.68 (3) χ 2 (2) = 3.98, p = .41 revealed statistically significant differences in total symptoms at T3 between the NS (0.86) and the SR (5.33) conditions (Z = −3.55, p < .001, effect size = .42), the NS (0.86) and the SD (11.40) conditions (Z = −5.65, p < .001, effect size = .70), and between the SR (5.33) and SD (11.40) conditions (Z = −2.27, p = .023, effect size = .28). When examining symptom clusters that comprise the total symptoms scores, significantly worse affective, cognitive, physical, and sleep complaints were observed within and between groups. Overall, significant differences were observed in individual symptoms following a night of SR and after a recovery night when compared with normal sleepers. Further, participants reported significantly worse affective, cognitive, and sleep complaints following a night of total SD and after a recovery night when compared with normal sleepers. The only statistically significant difference in subjective symptoms between those restricted of sleep and those deprived of sleep was found in sleep complaints. Specifically, only after a recovery night, those deprived of sleep endorsed significantly greater severity of sleep complaints than those restricted of sleep, suggesting that subjective sleep complaints are dose dependent. A full breakdown of the statistical results is provided in Supplementary material online.
Objective Neurocognitive ImPACT Tasks
Within-group differences. The median scores of ImPACT tasks and the related-samples Friedman's two-way analysis of variance by ranks of ImPACT tasks over time for the NS, SR, and SD conditions are provided in Table 6 . Comparisons between T1 and T2, and T2 and T3 are provided in the following analyses. Differences between T1 and T3 are not reported as they represent the combined effect of changes observed between T1 and T2, and T2 and T3. Only statistically significant findings are reported below, and a full analysis is provided in Supplementary material online.
Significant results were found between the administration times for a task (Design Memory percent correct) that loads onto the Visual Memory Index for all three sleep conditions. Median Design Memory percent correct scores were significantly different between time points during the NS (χ 2 (2) = 13.96, p = .001), SR (χ 2 (2) = 14.32, p = .001), and SD (χ 2 (2) = 26.34, p < .001) conditions. During the NS condition, Wilcoxon signed-rank test post hoc analyses (see Table 7 ) revealed significant increases in scores between T1 and T2 (Z = −2.99, p = .003, effect size = .36), but not between time points 2 and 3. During the SR condition, significant increases in scores were observed between T2 and T3 (Z = −2.56, p = .011, effect size = .29), but not between T1 and T2. During the SD condition, significant increases in scores were observed between T2 and T3 (Z = −3.18, p = .001, effect size = .40), and approached significance between T1 and T2 (Z = −2.37, p = .018, effect size = .30).
Significant results were found between the administration times for a Reaction Time Index task (Color Match average RT) during the NS (χ 2 (2) = 23.95, p < .001) and SR (χ 2 (2) = 9.86, p = .007) conditions. During the NS condition, Wilcoxon signed-rank test post hoc analyses revealed significant reductions in reaction time between T1 and T2 (Z = −2.76, p = .006, effect size = .33), and T2 and T3 (Z = −3.37, p = .001, effect size = .40). During the SR condition, the reductions in reaction time were not statistically significant after applying the correction for multiple comparisons. Differences in Median Color Match average correct RT scores at the different time points during the SD condition were not statistically significant, and increased between T1 and T2 before returning to a reaction time similar to T1 after a recovery night. Notes: *p < .017, **p < .01, ***p < .001. Adjusted p-values with Bonferroni correction. Table 4 . T1, T2, and T3 medians (and ranges) of subjective ImPACT tasks, and Kruskal-Wallis H-tests median or mean rank between-group (NS, SR, and SD) differences Significant results were found between the administration times for a Visual Motor Speed Index task (3 Letters (interference) numbers counted correctly) during the NS condition only (χ 2 (2) = 21.85, p < .001). Wilcoxon signed-rank test post hoc analyses revealed significant increases in number correct between T2 and T3 (Z = −3.14, p = .002, effect size = .38), and the difference between T1 and T2 approached significance (Z = −2.12, p = .034, effect size = .26),
Between-group differences. The median scores of ImPACT objective tasks and Kruskal-Wallis H-tests between-group differences at T1, T2, and T3 are provided in Table 8 . Only statistically significant findings are reported below, and a full analysis is provided in Supplementary material online.
The only significant between-group difference that survived the Bonferroni correction for multiple comparison was observed on a Visual Motor Speed Index task (3 Letters (interference) numbers counted correctly). The mean rank scores were significantly different between groups (χ 2 (2) = 10.53, p = .005) at T1 only. Post hoc analysis revealed a significant difference in correct number between the NS (19.83) and SR conditions (23.43; Z = −3.16, p = .002, effect size = .38) only.
Discussion
The purpose of this study was to examine the effects of SD and SR compared with NS on subjectively reported cognitive, affective, physical, and sleep symptoms, and on objective neurocognitive performance as measured by ImPACT in a sample of healthy young adults without concurrent psychiatric, medical, sleep, or post-concussive disorders. We hypothesized that: (a) participants in the sleep loss conditions would endorse greater subjective complaints and demonstrate poorer performance on objective ImPACT tasks; (b) the amount of sleep loss would have a dose-dependent effect on subjectively reported symptoms and performance on objective ImPACT tasks; and (c) some neurocognitive domains may be more vulnerable to the effect of sleep loss, whereas others may be more resistant.
Partially supporting our first hypothesis, in this sample, both doses of sleep loss were associated with increased severity of subjective symptoms. However, no marked impairments were detected on objective neurocognitive tasks relative to the participants' baseline performance. Although these findings are consistent with a previous meta-analysis suggesting that sleep manipulation, particularly SD, negatively affects subjective reports of fatigue and mood symptoms more so than performance on cognitive and motor tasks (Pilcher & Huffcutt, 1996) , this is the first study that we are aware of to examine the effects of two doses of sleep loss using ImPACT and self-report sleep measures in a sample of non-concussed, healthy adults, whose sleep and amount of sleep loss were closely monitored in a controlled laboratory setting rather than relying on self-report to monitor sleep duration.
Participants in both the SR and SD groups reported significantly worse daytime and sleep complaints following a night of sleep loss and after a recovery night when compared with normal sleepers. This finding is consistent with previous sleep manipulation studies that have reported a significantly greater amount of behavioral symptoms in individuals endorsing nonhabitual low sleep quantity compared with those who report better overall sleep (Benitez & Gunstad, 2012; McClure, Zuckerman, Kutscher, Gregory, & Solomon, 2013; Mihalik et al., 2013) . Contrary to our second hypothesis and previous research that indicates that SD negatively effects neurobehavioral functioning to a greater magnitude than SR (Drake et al., 2001; Van Dongen, Maislin, Mullington, & Dinges, 2003) , the only statistically significant difference in subjective symptoms between those restricted of sleep and those deprived of sleep was found in sleep complaints. Specifically, only after a recovery night, those deprived of sleep endorsed significantly greater severity of sleep complaints than those restricted of sleep, suggesting that subjective sleep complaints are dose dependent, and that one recovery night was not sufficient to return symptoms to baseline. Additionally, these findings suggest that amount of sleep loss may affect neurobehavioral functioning, with the exception of sleep symptoms, differently in acute compared with chronic loss of sleep. This is consistent with recent research demonstrating chronic SR (over 14 days) negatively affects performance on tasks of sustained attention and working memory in a dose-dependent manner (Van Dongen et al., 2003) . Objective neurocognitive task scores derived from the ImPACT battery did not corroborate subjective complaints. As objective and subjective sleep and neuropsychological reports/measures are unsurprisingly discrepant, this suggests that sleep and neuropsychological reports/measures likely capture different dimensions of cognitive experiences and functions. Although our first hypothesis was not entirely supported, our third hypothesis was supported as significant differences in objective performance across time were observed on one visual memory task and two reaction time tasks for participants in the SR group; one visual memory task and one reaction time task for those in the SD group; and one visual memory task, one reaction time task, and one visual motor speed task for normal sleepers. One task of visual memory (Design Memory) revealed significant improvements in score between T1 and T3 for participants in all three conditions (See Fig. 1) . However, the improvements in score occurred at different time points. Normal sleepers demonstrated significant increases in score from T1 to T2 and not between T2 and T3, whereas those in the sleep loss conditions did not demonstrate significantly improved performance following a night of sleep loss until after a recovery night. Taken together, as the improvement in design memory that was found between T1 and T2 in normal sleepers was not observed in the SR or SD groups, it appears that this task of visual memory may be sensitive to capturing negative effects of sleep loss on visual learning and memory (Figs. 2-4) .
It can be posited that these findings are consistent with the previous literature that indicates visual memory capacity may be significantly reduced among individuals with one night of SD when compared with controls (Chee & Chuah, 2007) . However, consistent with the concept that various components that comprise specific cognitive functions can be affected differently by sleep loss (Drummond, Anderson, Straus, Vogel, & Perez, 2012) , Drummond and colleagues (2012) demonstrated that total SD negatively affects visual memory by compromising the ability to filter between relevant and irrelevant stimuli. Given the demands of the design memory task, the current findings likely reflect an alteration in visual memory capacity following sleep loss rather than a dysregulated filtration process, and that this effect was measurable by utilizing ImPACT even in a healthy, non-concussed sample.
On a task (Color Match) of visual-motor reaction time, focused attention and response inhibition (the ability to attend to inbound stimuli and impede an automatic response; Lezak, Howieson, Loring, Hannay, & Fischer, 2004) , post hoc analyses revealed that there were significant improvements in performance between T1 and T2, and T2 and T3 during the NP condition only. These improvements did not exist for the SR and SD conditions, suggesting that reaction time on a Stroop analog task is negatively affected by sleep loss. While the differences in performance between time points for the sleep loss conditions were not significant, there were observable trends that warrant further examination. Following a night of Notes: *p < .017, **p < .01, ***p < .001. Adjusted p-values with Bonferroni correction. Table 8 . T1, T2, and T3 medians (and ranges) of ImPACT tasks, and Kruskal-Wallis H-tests median or mean rank between-group (NS, SR, and SD) differences
Verbal Memory Index Word Memory % Correct SR, the improvement in reaction time approached significance then remained unchanged following a recovery night. Consistent with findings that report the ability to inhibit an automatic response is negatively affected by total SD (Drummond, Paulus, & Tapert, 2006) , those in the SD group demonstrated slower reaction time subsequent to sleep loss, followed by a return to baseline subsequent to a recovery night. While it appears as though recovery of reaction time is more prominent for those completely deprived of sleep, this effect should be interpreted with caution, as the individuals in the SD group were the only group that did not show improved reaction time at T3 relative to their baseline. Taken together, these findings suggest that reaction time was acutely and negatively affected by sleep loss in a dose-dependent manner, and that these changes can be captured utilizing ImPACT. Any improvements in reaction time may be due to familiarity with the task due to practice, but this effect was not present under total SD. On a task of visual motor speed (3 Letters (interference) # Correct), post hoc analyses revealed that there were significant improvements in performance from T2 to T3 in the NS condition, and that the improvement in performance from T1 to T2 approached significance. These improvements in performance did not exist for those in the sleep loss conditions, suggesting that visual motor speed as measured by ImPACT may be negatively influenced by sleep loss in the absence of current concussive or psychiatric symptoms. This result is consistent with the previous literature that indicates tasks of processing speed have been found to be susceptible to the effects of sleep loss (Dinges, 1992; Goel et al., 2009 ).
Any change (or absence of change) in neurocognitive performance as measured by ImPACT may not accurately capture the neurobehavioral manifestations of sleep loss. The results of the present analyses yielded a majority of nonsignificant findings that nevertheless suggest a potential pattern of cognitive deficits following acute sleep loss. Upon further exploration, the observed variability in performance (i.e., improvement on one task and not on others) within the Verbal Memory Index and Visual Memory Index between the SR and SD groups relative to the NS group following the night of sleep loss suggests that different neural networks or brain regions governing performance on specific tasks may be differentially affected by sleep loss. For instance, results indicated that performance on the different tasks within the Visual Motor Speed Index between the sleep loss groups remained relatively consistent over time, suggesting that performance on this task may not, in fact, be vulnerable to acute sleep loss, where as a dose-dependent effect was observed for reaction time.
As stated earlier, significant improvements in reaction time were observed over time for those in the NS condition only. This is consistent with numerous studies showing that acute total or partial sleep loss affect reaction time (Dinges, 1992; Dinges et al., 1997; Van Dongen et al., 2003) . However, the between-group analysis revealed that participants in the SR group demonstrated better performance than even those in the NS condition, where those in the SD group demonstrated slower performance, relative to the NS group. These patterns in performance were not demonstrated following a night of sleep restoration. This finding, although not significant, suggests that there may be an amount of acute sleep loss that can be overcome by compensatory neural mechanisms to improve reaction time, but that when sleep loss exceeds a certain threshold, these mechanisms are insufficient to counteract the negative effects of sleep loss. This could be likened to the recruitment of compensatory neural mechanisms when completing tasks identified as being more challenging (Drummond et al., 2000 (Drummond et al., , 2001 (Drummond et al., , 2004 (Drummond et al., , 2005 . This finding also suggests that the dose-dependent effects of sleep loss are not only based upon the number of consecutive hours of sleep loss, but also on the total duration of sleep loss over time. Previous research has demonstrated that chronic SR (over 14 days) can have the same negative effects on neurocognitive functioning as 1-2 days of total SD (Van Dongen et al., 2003) . Future research should examine the threshold amount of days that an individual can be restricted of sleep prior to demonstrating negative cognitive performance.
Identifying neural connectivity patterns can aid in the progression of recognizing biomarkers involved in various disorders (Zhou et al., 2010) . Advancements in neuroimaging have provided evidence related to the underlying neural intrinsic connectivity networks (Damoiseaux et al., 2006; Seeley et al., 2007) . These networks represent brain regions in which neural activity fluctuates in a specific and reliable manner, even under various mental states including sleep (Bressler & Menon, 2010; Greicius et al., 2008; Horovitz et al., 2009; Vanhaudenhuyse et al., 2010) . While there are numerous intrinsic connectivity networks that have been identified to date, three core neurocognitive networks have been indicated to be closely involved in cognitive processes (Menon, 2011; Smith et al., 2009) . These networks include the central executive network, salience network, and default mode network (Fox & Raichle, 2007; Greicius, Krasnow, Reiss, & Menon, 2003; Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 2004; Seeley et al., 2007; Sridharan, Levitin, & Menon, 2008) . Fig. 1 . Between-group differences in subjectively reported sleep symptoms (top) and total symptoms (bottom).
Research has indeed indicated that it is the activation, deactivation, and interaction of these networks that predict cognitive control and performance (Fox et al., 2005; Germain, Hall, Krakow, Shear & Buysse, 2005; Hampson, Driesen, Roth, Gore, & Constable, 2010; Kelly, Uddin, Biswal, Castellanos, & Milham, 2008; Schmaal et al., 2013; Seeley et al., 2007; Spreng, Stevens, Chamberlain, Gilmore, & Schacter, 2010) . More neuroimaging studies probing the relationship between sleep loss and these neural networks are required. This study has a number of limitations that should be acknowledged. Drawing conclusions regarding the generalizability of the results is difficult, as sleep loss has been shown to affect neurocognitive performance differently in different populations (Wesensten, Hughes, & Balkin, 2012) . Future research that includes the administration of comprehensive neuropsychological batteries in addition to the ImPACT battery may help to validate the findings of the present study. The selected neuropsychological battery would have to be carefully selected, however, in order to avoid the effects of practice on measures that do not have alternate equivalent versions.
Given that the participants in the parent studies were all free of comorbid sleep and psychiatric disorders, we are unable to rule out the possibility that ImPACT may be sensitive to changes in neurocognitive performance in other samples. Furthermore, we cannot verify the accuracy of the retrospective, self-reports of head injury, or the potential residual effects of these previous head injuries on current performance. Any observed improvements in performance may be due to a practice effect from exposure to the presented stimuli rather than a function of sleep. However, the test modules comprising ImPACT contain virtually unlimited substitute forms by alternating the presented stimuli for each administration at random, theoretically reducing any effects of practice specific to test stimuli (https://www.impacttest.com/about/). However, participants may have become familiar with the procedure and developed strategies to facilitate the observed performance. Finally, we are not able to speak to the effects of chronic sleep disruption on ImPACT performance. The previous literature has shown that chronic SR (two or more consecutive nights with less than 8 h of sleep) has dose-dependent negative effects on neurocognitive performance (Wesensten et al., 2012) . Future studies should examine whether ImPACT may be more sensitive to the effects of chronic SR than it is for acute sleep manipulation.
Despite these limitations, this is the first study to examine the effects of two doses of SR and SD on neurocognitive performance using ImPACT and self-report sleep measures in a sample of currently non-concussed, healthy adults. Additionally, the amount of sleep loss was closely monitored in a controlled laboratory setting rather than relying on self-report to monitor sleep duration. Results from this exploratory study suggest that both SR and SD affect visual memory and learning, reaction time, response inhibition, and visual-motor processing speed in non-concussed individuals.
The observed changes in cognitive performance in the present study may also exist in other populations that have not been typically evaluated utilizing ImPACT. Further, it is possible that these changes may be more pronounced depending upon the sample that is evaluated. The neurocognitive functions measured by ImPACT that were observed to be dose dependent and sensitive to sleep loss in this study play vital roles to the functioning and survival of personnel in high-stress, high-risk occupations (i.e., emergency workers, first responders, and military service members). We are unable to speculate as to how the findings of this study would translate to members in these settings, as stress has been demonstrated to have both positive and negative effects on performance (Lupien, Maheu, Tu, Fiocco, & Schramek, 2007) For military personnel where high stress and chronic sleep loss are the norm rather than the exception, any changes in neurocognitive performance may be compounded by both acute and chronic stressors, as well as sleep loss. ImPACT could play a critical role in the evaluation of military service members as the prevalence rates of TBI in this population range between 15% and 33% (Barr et al., 2015; Hoge et al., 2008; Tanielian & Jaycox, 2008; Terrio et al., 2009; Troyanskaya et al., 2015; Warden, 2006) . While this leaves a larger percentage that have not reported sustaining TBI, as sleep loss is an even more prevalent condition, utilizing ImPACT to monitor the changes in neurocognitive performance associated with sleep loss in service members could be a step toward enhancing the operational effectiveness during deployment by objectively monitoring cognitive performance.
Finally, any change (or absence of change) in neurocognitive performance as measured by ImPACT may manifest differently in different populations. As such, it is recommended that an emphasis in treatment be placed upon the subjectively endorsed cognitive, affective, psychical, and sleep complaints if ImPACT is ever administered to non-concussed patients or participants endorsing sleep loss, regardless of the findings of objective cognitive data. Researchers and clinicians are urged to base clinical impressions of neurocognitive performance and the effects of sleep dysregulation upon the examination of multiple sources of information, including, but not limited to, objective data and subjective report. This could ultimately allow for the development and implementation of strategies to effectively guide treatment across multiple populations. 
